92 related articles for article (PubMed ID: 30488209)
1. Association of Target Therapy Gene Expression with Metastasizing of Clear-Cell Renal Cell Carcinoma.
Apanovich NV; Peters MV; Apanovich PV; Markova AS; Kamolov BS; Matveev VB; Karpukhin AV
Bull Exp Biol Med; 2018 Dec; 166(2):257-259. PubMed ID: 30488209
[TBL] [Abstract][Full Text] [Related]
2. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
3. Expression Profiles of Genes-Potential Therapy Targets-and Their Relationship to Survival in Renal Cell Carcinoma.
Apanovich NV; Peters MV; Apanovich PV; Kamolov BS; Matveev VB; Ginter EK; Karpukhin AV
Dokl Biochem Biophys; 2018 Jan; 478(1):14-17. PubMed ID: 29536301
[TBL] [Abstract][Full Text] [Related]
4. Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma.
Joseph RW; Parasramka M; Eckel-Passow JE; Serie D; Wu K; Jiang L; Kalari K; Thompson RH; Huu Ho T; Castle EP; Cheville J; Kwon ED; Thompson EA; Parker A
Cancer Immunol Res; 2013 Dec; 1(6):378-85. PubMed ID: 24778130
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
6. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.
Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C
Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
8. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
[TBL] [Abstract][Full Text] [Related]
9. miRNAs as potential regulators of mTOR pathway in renal cell carcinoma.
Nogueira I; Dias F; Teixeira AL; Medeiros R
Pharmacogenomics; 2018 Feb; 19(3):249-261. PubMed ID: 29334302
[TBL] [Abstract][Full Text] [Related]
10. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
[TBL] [Abstract][Full Text] [Related]
11. Loss of PIG3 increases HIF-1α level by promoting protein synthesis via mTOR pathway in renal cell carcinoma cells.
Chen G; Xu JY; Chen J; Zhang JX; Zhou J; Liang Y; Ding XF
Oncotarget; 2016 May; 7(19):27176-84. PubMed ID: 27029070
[TBL] [Abstract][Full Text] [Related]
12. The prospect of precision therapy for renal cell carcinoma.
Ciccarese C; Brunelli M; Montironi R; Fiorentino M; Iacovelli R; Heng D; Tortora G; Massari F
Cancer Treat Rev; 2016 Sep; 49():37-44. PubMed ID: 27453294
[TBL] [Abstract][Full Text] [Related]
13. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.
Lin YC; Lu LT; Chen HY; Duan X; Lin X; Feng XH; Tang MJ; Chen RH
Cancer Res; 2014 Dec; 74(23):6935-46. PubMed ID: 25293974
[TBL] [Abstract][Full Text] [Related]
14. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
[TBL] [Abstract][Full Text] [Related]
15. Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling.
Yang Z; Xie H; He D; Li L
Oncotarget; 2016 Jul; 7(28):44478-44491. PubMed ID: 27283897
[TBL] [Abstract][Full Text] [Related]
16. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations and role of the LKB1 gene as a tumor suppressor in renal cell carcinoma.
Yalniz Z; Tigli H; Tigli H; Sanli O; Dalay N; Buyru N
Tumour Biol; 2014 Dec; 35(12):12361-8. PubMed ID: 25179843
[TBL] [Abstract][Full Text] [Related]
18. Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.
Chen YS; Meng F; Li HL; Liu QH; Hou PF; Bai J; Zheng JN
Oncotarget; 2016 Dec; 7(51):84299-84313. PubMed ID: 27732931
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of UBB potentiates SP1/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma.
Wang J; Zhao E; Geng B; Zhang W; Li Z; Liu Q; Liu W; Zhang W; Hou W; Zhang N; Liu Z; You B; Wu P; Li X
Oncogene; 2024 May; 43(18):1386-1396. PubMed ID: 38467852
[TBL] [Abstract][Full Text] [Related]
20. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]